JUPITER NEUROSCIENCES, INC. (39)
Browse by Contract Category
Contracts
-
Third Amendment to the Securities Purchase Agreement, dated as of January 13, 2013, between the Company and Puritan Partners LLC
(Filed With SEC on January 17, 2023)
-
Peer Review Summary Statement of FA Grant Application
(Filed With SEC on January 6, 2023)
-
Master Services Agreement, dated as of December 27, 2022, between the Company and Titan Advisory Services
(Filed With SEC on January 6, 2023)
-
License Agreement with Aquanova AG
(Filed With SEC on November 9, 2021)
-
Employment Agreement, dated as of September 1, 2021, between the Company and Christer Rosn
(Filed With SEC on October 12, 2021)
-
Second Amendment to the Securities Purchase Agreement, dated as of November 10, 2022, between the Company and Puritan Partners LLC
(Filed With SEC on December 2, 2022)
-
Amendment to the Securities Purchase Agreement, dated as of October 10, 2022, between the Company and Puritan Partners LLC
(Filed With SEC on December 2, 2022)
-
Research Agreement, dated July 1, 2022, between the Company and University of Miami
(Filed With SEC on August 26, 2022)
-
Form of Strategic Services Agreement
(Filed With SEC on August 16, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on August 16, 2022)
-
Senior Secured Convertible Promissory Note, dated as of April 11, 2022, issued by the Company in favor of Puritan Partners LLC
(Filed With SEC on April 26, 2022)
-
Securities Purchase Agreement, dated April 11, 2022, between the Company and Puritan Partners LLC
(Filed With SEC on April 26, 2022)
-
Intellectual Property Security Agreement, dated April 11, 2022, between the Company and Puritan Partners LLC
(Filed With SEC on April 26, 2022)
-
Security Agreement, dated April 11, 2022, between the Company and Puritan Partners LLC
(Filed With SEC on April 26, 2022)
-
Form of Warrant (Annex C to the Form of Warrant Agent Agreement attached as Exhibit 4.2)
(Filed With SEC on January 5, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on January 5, 2022)
-
Debt Forgiveness and Exchange Agreement, dated as of December 1, 2021, between the Company and Aquanova AG
(Filed With SEC on December 17, 2021)
-
Agreement between the Company and Syneos Health
(Filed With SEC on November 9, 2021)
-
Amendment to Services Agreement between the Company and Technical Resources International, Inc
(Filed With SEC on November 9, 2021)
-
Services Agreement between the Company and Technical Resources International, Inc
(Filed With SEC on November 9, 2021)
-
Material Transfer Agreement between the Company and University of Miami
(Filed With SEC on November 9, 2021)
-
Manufacturing Agreement between Company and Catalent
(Filed With SEC on November 9, 2021)
-
Grant Agreement between Company and National Institute on Aging
(Filed With SEC on November 9, 2021)
-
Agreement between Company and Murdoch Childrens Research Institute
(Filed With SEC on November 9, 2021)
-
Employment Agreement, dated as of September 1, 2021, between the Company and Alison Silva
(Filed With SEC on October 12, 2021)
-
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Christer Rosn
(Filed With SEC on October 12, 2021)
-
Employment Agreement, dated as of September 1, 2021, between the Company and Marshall Hayward, Ph.D
(Filed With SEC on October 12, 2021)
-
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Marshall Hayward, Ph.D
(Filed With SEC on October 12, 2021)
-
Employment Agreement, dated as of June 6, 2021, between the Company and Alexander Rosn
(Filed With SEC on October 12, 2021)
-
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Alexander Rosn
(Filed With SEC on October 12, 2021)
-
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Dana Eschenburg Perez
(Filed With SEC on October 12, 2021)
-
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Alison D. Silva
(Filed With SEC on October 12, 2021)
-
Employment Agreement, dated as of June 1, 2021, between the Company and Dana Eschenburg Perez
(Filed With SEC on October 12, 2021)
-
Independent Director Agreement, dated as of September 8, 2021, between the Company and Nicholas H. Hemmerly
(Filed With SEC on October 12, 2021)
-
Independent Director Agreement, dated as of September 8, 2021, between the Company and Julie Kampf
(Filed With SEC on October 12, 2021)
-
Independent Director Agreement, dated as of September 8, 2021 between the Company and Alison W. Brady
(Filed With SEC on October 12, 2021)
-
Independent Director Agreement, dated as of September 8, 2021, between the Company and John Ditton
(Filed With SEC on October 12, 2021)
-
Independent Director Agreement, dated as of September 8, 2021, between the Company and Holger Weis
(Filed With SEC on October 12, 2021)
-
Jupiter Orphan Therapeutics, Inc. 2021 Equity Incentive Plan
(Filed With SEC on October 12, 2021)